New ME/CFS Blood Test Could Transform Diagnosis for Many Patients

Skepticism and misinformation make chronic fatigue syndrome an isolating illness. In a previous study, almost 70% of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients reported facing high stigma. A third of ME/CFS patients and half of male patients had suicidal thoughts.

Both medical professionals and community members often fail to recognize the disease. This lack of recognition leads to inadequate support for patients. Many people with ME/CFS are dismissed or misunderstood when describing their severe symptoms.

A recent study in the Journal of Translational Medicine may help reduce stigma. Researchers identified a specific blood signature in patients with severe ME/CFS. They developed a diagnostic test using 200 bloodline markers. The test can identify ME/CFS with 96% accuracy.

These findings offer hope for patients long dismissed or doubted. A reliable diagnostic tool could validate their suffering and improve medical support.

How Did Researchers Create Their New ME-CFS Blood Test?

Researchers built their new ME-CFS test to track epigenetic changes. These changes reflect how gene expression shifts due to environmental or behavioral factors. The test was developed using a pre-existing platform called EpiSwitch®. This system allowed researchers to examine epigenetic regulators in 47 patients with severe ME-CFS symptoms.

The team compared these results with data from 61 healthy participants. They identified 200 epigenetic markers that correctly diagnosed ME-CFS 96% of the time. This strong accuracy rate suggests the test could be a breakthrough for diagnosis.

EpiSwitch® has a proven track record in other medical applications. It helped researchers develop diagnostic tests for prostate cancer. However, ME-CFS is far more complex to diagnose. Its symptoms vary widely from person to person, making consistency difficult.

Experts still don’t know whether all ME-CFS cases share a single cause. It’s possible that multiple factors interact to worsen the disease’s effects. Many ME-CFS symptoms also resemble those of other conditions, complicating diagnosis.

What Concerns and Steps Remain Before This Test Can Be Used?

This discovery offers hope to those who have long suffered with ME-CFS. Many patients have faced years of misunderstanding and misdiagnosis. However, several organizations and medical professionals remain cautious about these findings.

The study found a strong systemic signal in patients with severe ME-CFS. This signal helped distinguish patients from healthy participants. Yet, when compared directly to healthy controls, the signal weakened. Researchers also did not include data from patients with mild or moderate ME-CFS.

The results were not compared to other conditions with similar symptoms. For a diagnostic test to be considered authoritative, both gaps must be addressed. These comparisons are essential to confirm that the test is accurate and specific.

The ME Association UK issued a statement regarding the new blood test. The group emphasized the need for high sensitivity and specificity to ME-CFS alone. Future research should show that the test can distinguish between early and late stages. It should also separate mild, moderate, and severe disease presentations.

The organization concluded that more studies are needed before the test can be used clinically. Until then, ME-CFS patients will need to wait for verified diagnostic tools.

Conclusion

A new ME-CFS blood test could transform diagnosis for many patients. Researchers must still confirm its accuracy across all disease stages and severities. If future studies succeed, this test could offer long-awaited validation and support.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.